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1. Introduction 
Today, the nanotechnology has achieved a development level reaching a stage where it is 
possible to produce and specially tailor the functional properties of nanoparticles (NPs) for 
biomedical and biotechnological applications (Gupta et al., 2007; Gupta & Gupta, 2005; 
Pankhurst et al., 2009). Among different types of NPs, magnetic (MNPs) and more recently, 
multifunctional magnetic nanoparticles (MFMNPs) have attracted a great deal of attention 
in nanomedicine over the past decade. These functionalized nanomagnets can be directly 
injected onto the body vessels and properly manipulated by an external magnetic force. The 
action at a distance and the non invasive technique provide tremendous advantages for 
these NPs uses, making these nanomaterial ideal for either in vitro or in vivo biomedical 
applications (de Dios & Díaz-Garcia, 2010; Lu et al., 2007; Salgueirino-Maceira & Correa-
Duarte, 2007). In the biomedicine area, their applications including magnetic resonance 
contrast agent in Magnetic Resonance Imaging (MRI), magnetohyperthermia for cancer 
treatment, magnetic force-assisted drug delivery, tissue repair, cell and tissue targeting and 
transfection, and protein isolation (Lu et al., 2007; Sanvicens & Marco, 2008; Varanda et al., 
2008). In this context, the combination of nanotechnology and molecular biology has 
developed into an emerging new class of nanomagnetics for biomedicine, which combine 
the MNP properties and the most modern surface engineering techniques resulting in 
biocompatible and bioselectable MFMNPs (de Dios & Díaz-Garcia, 2010; Majewski & 
Thierry, 2007; Salgueirino-Maceira & Correa-Duarte, 2007; Selvan et al., 2010).  
Down to the nanoscale, on the order of around two dozen or less, the magnetic particles 
change from paramagnetic to superparamagnetic (SPM) behavior, where magnetic moment 
of the particle as a whole is free to fluctuate in response to thermal energy, while the 
individual atomic moments maintain their ordered state relative to each other. Thus, the 
superparamagnetic NPs can only be magnetized in the presence of an external magnetic 
field and do not retain any magnetism after removal of the magnetic field, which makes 
www.intechopen.com
 Biomedical Engineering, Trends in Materials Science 
 
398 
them capable of forming stable colloids in a physio-biological medium (Lu et al., 2007; 
Majewski & Thierry, 2007; Santos et al., 2008; Sorensen, 2001; Varanda et al., 2002a; Varanda 
et al., 2001; Varanda et al., 2007; Varanda et al., 2008; Varanda & Jafelicci, 2006). Combining 
the SPM behavior with appropriate surface functionalizations, besides other intrinsic NPs 
properties such as low cytotoxicity, bioactivity and ability to conjugate with optically active 
molecules or compounds, makes their multifunctionalized nanomaterials strong biomedical 
tools for using in sensing, diagnostic or therapy fields. It appears reasonable to accurately 
consider that the aim of surface modification is not only to stabilize the NP suspension in 
vitro and govern their in vivo fates, but also to minimize the remnant magnetization. It is 
now recognized that internalization of particle also depends strongly on the size of the 
magnetic particle (Gupta et al., 2007). In addition, successive surface modifications realized 
to obtain functional or multifunctional NPs generally require additions of the non-magnetic 
materials on MNPs surface. Thus, at the final of the functionalization process, the magnetic 
core emanation has been dramatically decreased and the efficient NP application was 
strongly compromised (Selvan et al., 2010; Sun et al., 2008; Varanda et al., 2008). Besides the 
morphological strict control required for the MNPs, which have been effectively achieved 
due to advances in synthetic routes, their use in biomedicine is guided by two key 
challenges: (i) the surface engineering to promote the chemical/biological functionalizations 
that lead to required biocompatibility and bioselectivity and (ii) improving the magnetic 
properties of the core in order to stand different functionalizations keeping the magnetic 
emanation at high enough levels for their effective applications. According to exposed, this 
Chapter focuses on the synthesis, protection, functionalization, and applications of the 
MNPs to the biomedical areas, as well as emphasizing the features of magnetic properties of 
nanostructured systems. In addition, also describe some potentially useful design and 
applications of MFMNPs for biomedicine, which have been attracting increased research 
efforts because of their easily accessible multimodality.  
2. Features and required properties of the magnetic nanoparticles 
According to several studies reported in the literature relating MNPs for biomedical 
applications and properly summarized in a bright review published by Gupta et al. (Gupta & 
Gupta, 2005), the effectiveness of these NPs depends upon: 
a. SPM behavior and high magnetic susceptibility for effective magnetic response even 
after multifuncionalization with non-magnetic compounds; 
b. narrow particle size distributions with size ranging from 6 to 20 nm. Particles below a 
critical size (~20 nm) would consist of a single magnetic domain (state of uniform 
magnetization at any field with superparamagnetism and high saturation 
magnetization values). In addition, the particles in this size range are rapidly removed 
through extravasations and renal clearance besides avoiding the capillary embolism. 
c. tailored/targeting surface chemistry for specific functionalization.  
Fundamental changes in the magnetic structure of ferro, ferri, and even antiferromagnetic 
materials when sizes are dramatically reduced for the nanoscale can be observed in the two 
most important effects, i.e., finite-size and highest-surface. In macroscopic scale or in large 
magnetic particles, there are magnetic domains regions (spins pointing in the same 
directions and acting cooperatively) with uniform magnetization separated by domain 
walls. The domain walls formation is driven by the balance between magnetostatic energy 
(ΔEM), directly proportional to the material volume, and the domain-wall energy (EDW), 
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which increases proportionally to the interfacial area between domains. As the particle size 
decreases toward some critical particle diameter (DC), the formation of domain walls 
becomes energetically unfavorable leading to the single-domain state. The multidomain to 
single-domain state limit is reached when ΔEM = EDW and the DC values can be easily 
calculated for many materials according to the magnetic particle properties such as 
magnetization, anisotropy constant, particle shape, etc (Batlle & Labarta, 2002). Changes in 
magnetization can no longer occur through domain-wall motion and instead require the 
coherent rotation of spins resulting in large coercivities. A single-domain particle, on the 
other hand, is uniformly magnetized with all the spins aligned in the same direction. The 
magnetization will be reversed by spin rotation since there are no domain walls to move. 
This is the reason for the very high coercivity observed in the small NPs (Lu et al., 2007). 
Continuos decreasing in the particle size below the single-domain value increasingly affect 
the spins by thermal fluctuations and the system becomes SPM (Salgueirino-Maceira & 
Correa-Duarte, 2007; Sorensen, 2001). Under SPM behavior, the mechanism of 
magnetization reversal can only occur via the rotation of the magnetization vector from  
magnetic easy axis to another via a magnetically hard direction (Stoner & Wohlfarth, 1948). 
However, the superparamagnetismo can be understood considering the magnetic 
anisotropy energy per particle, which is responsible for holding the magnetic moments 
along a certain direction. This energy barrier to moment reversal has several origins 
including both intrinsic and extrinsic effects, such as the magnetocrystalline and shape 
anisotropies, respectively, but used as a simplest form expressing the uniaxial effect or an 
effective anisotropy constant, Keff. This energy barrier is given by:  
 2sin= effE K V θ , (1) 
where V is the particle volume and θ is the angle between the magnetization and the easy 
axis. With decreasing particle size, the thermal energy kBT exceed the energy barrier KeffV, in 
which kB and T is the Boltzmann’s constant and the temperature, respectively. This direct 
proportionality between E and V is the reason that superparamagnetism (the thermally 
activated flipping of the net direction of the magnetic moment) is very important for small 
particles, because for them E is comparable to thermal energy at room temperature. For kBT 
> KeffV the system behaves like a paramagnetic, instead of atomic magnetic moments, there 
is now a giant (super) moment inside each particle. The underlying physics of 
superparamagnetism is founded on activation for the relaxation time τ of particle net 
magnetization given by Néel-Brown (Eq. 2) (Lu et al., 2007; Sorensen, 2001) where τ0 ≈ 10-9 s.  
 ( )0 /= eff Bexp K V k Tτ τ  (2) 
Thus, it is important to recognized that observations of superparamagnetism are implicitly 
dependent not only the temperature, but also on the measurement time, τm, of the used 
experimental technique (Salgueirino-Maceira & Correa-Duarte, 2007). If the particle 
magnetic moment reverses at times shorter than the experimental time scale, the system is in 
a SPM state, if not, it is in the so-called blocked state. The temperature, which separates 
these two regimes, the so-called blocking temperature, TB, can be calculated by considering 
the time window of the measurement. The blocking temperature depends on the effective 
anisotropy constant, the size of the particles, the applied magnetic field, and the 
experimental measuring time. For example, if the blocking temperature is determined using 
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a technique with a shorter time window, such as ferromagnetic resonance which has a τ ≈ 
10-9 s, a larger value of TB is obtained than the value obtained from dc magnetization 
measurements. Moreover, a factor of two in particle diameter can change the reversal time 
from 100 years to 100 nanoseconds. While in the first case the magnetism of the particles is 
stable, in the latter case the assembly of the particles has no remanence and is SPM.  
The second observed effect as the particle size decreases is related to the large percentage of 
all atoms in the NPs is surface atoms. This characteristic implies that surface and/or 
interface phenomena become more significant and important for the nanosized system 
properties, such as reactivity, and colloidal/chemical stabilities. According to the NP size 
and structure, it is usual to find about 60-70% of the total number of spins as surface spins. 
Immediate consequence of the large surface atoms/bulk atoms ratio is the local breaking of 
the structure symmetry might lead to changes in the band structure, lattice constant, and/or 
atoms coordination, which make an important contribution, besides other materials 
properties, to the NP magnetization. Under these conditions, surface/interface effects such 
as surface anisotropy occur and, in addition, according to the phases present on the NP 
surface and bulk, core-surface exchange anisotropy or interactions take place changing the 
resulting magnetic properties (Benitez et al., 2008; Hyeon et al., 2001; Hyeon, 2003b; Lu et al., 
2007; Varanda et al., 2008). 
3. Synthesis of magnetic nanoparticles 
It has long been of scientific and technological challenge to synthesize the MNPs of 
customized size and shape (Gupta & Gupta, 2005). In a general way, physical methods such 
as gas phase deposition and electron beam lithography are elaborate procedures that suffer 
from the inability to control the size of particles in the nanometer size range  (Pratsinis & 
Vemury, 1996; Rishton et al., 1997). The wet chemical routes to MNPs are simpler, more 
tractable and more efficient with appreciable control over size, chemical composition and 
sometimes even the shape of the NPs (Hyeon, 2003b; Malheiro et al., 2007; Santos et al., 2008; 
Sun et al., 2000; Sun & Zeng, 2002; Varanda & Jafelicci, 2006). Considering the high number 
of potential applications for high quality MNPs, especially for iron oxide case focused in the 
biomedical applications, it is not surprising that numerous synthetic routes have been 
described with different level of control on the size, polydispersity, shape, and crystallinity. 
Concerning only the wet chemical routes, the MNPs have been synthesized with a number 
of different compositions and phases, including iron oxides, such as Fe3O4 and γ-Fe2O3 
(Hyeon et al., 2001; Mornet et al., 2006; Sun & Zeng, 2002), pure metals, such as Fe, Ni and 
Co (Puntes et al., 2001), spinel-type structure as ferrite of Mg, Mn, and Co (Park et al., 2004), 
as well as alloys, such as CoPt and FePt (Varanda & Jafelicci, 2006). Especially during the 
last few years, many publications have described efficient synthetic routes to shape-
controlled, highly stable, and monodisperse MNPs. Several popular methods including co-
precipitation, thermal decomposition/reduction, micelle synthesis, hydrothermal synthesis, 
and laser pyrolysis techniques can all be directed at the synthesis of high-quality MNPs. The 
most widely general accepted mechanism of the particles preparation in the solution under 
optimum synthetic conditions takes place by the rapid and homogenous formation of nuclei 
in a supersaturated medium, followed by controlled crystal growth, according to the well-
known LaMer’s diagram (LaMer & Dinegar, 1950). The latter process is controlled by mass 
transport and by the surface equilibrium of addition and removal of individual monomers, 
i.e., atoms, ions, or molecules. Hereby, the driving force for monomer removal increases 
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with decreasing particle size. Thus, within an ensemble of particles with slightly different 
sizes, the large particles will grow at the cost of the small ones. This mechanism is called 
Ostwald ripening and is generally believed to be the main path of crystal growth. Magnetite 
particles obtained under different synthetic conditions, for example, may display large 
differences regarding their magnetic properties. These differences are attributed to changes 
in structural disorder, creation of antiphase boundaries, or the existence of a magnetically 
dead layer at the particle surface (Gupta & Gupta, 2005). The saturation magnetization (Ms) 
values found in nanostructured materials are usually smaller than the corresponding bulk 
phases, provided that no change in ionic configurations occurs. Accordingly, experimental 
values for Ms in magnetite NPs have been reported to span the 30–50 emu/g range, lower 
than the bulk magnetite value of 90 emu/g. Many studies have been reported on the origin 
of the observed reduction in magnetization in fine magnetic particles generally concerning 
the high-surface effects. The first studies on the decrease in magnetization performed in γ-
Fe2O3 showed that this reduction is due to the existence of noncollinear spins at the surface. 
Also, in magnetite fine particles, Varanda et al. have reported a linear correlation between 
saturation magnetization and particle size, suggesting that defects at the particle surface can 
influence the magnetic properties. The surface curvature of the NP was much larger for 
smaller particle size, which encouraged disordered crystal orientation on the surface and 
thus resulted in significantly decreased Ms in smaller NPs (Varanda et al., 2002b). In this 
context, advancement in the use of magnetic particles for biomedical applications depends 
on the new synthetic methods with better control of the size distribution, magnetic 
properties and the particle surface characteristics. Typical and representative discussion of 
each main synthetic pathway in a general form is presented and the main features of the 
different routes are summarized in the Table 1. Today, the most used MNPs as potential 
magnetic materials for biomedical applications are based on the magnetic iron oxide NPs, 
generally described as SPION (SPM iron oxide nanoparticles) (Roca et al., 2009). 
Nevertheless, most of the NPs available to date have been prepared using variations of the 
aqueous co-precipitation method. In these processes, a nucleation phase is followed by a 
growth phase with good control over de particle size and polydispersity. Iron oxides, either 
Fe3O4 (magnetite) or γ-Fe2O3 (maghemite), can be synthesized from aqueous mixture of Fe2+ 
and Fe3+ salt solutions by the addition of a base under inert atmosphere at controlled 
temperature. The size, shape, and chemical composition of the MNPs are strongly 
dependents on the salts (e.g. chlorides, sulfates, nitrates, etc.), the Fe2+/Fe3+ ratio, the 
reaction temperature, the pH value and ionic strength of the medium. According to the 
thermodynamics of this reaction, a complete precipitation of Fe3O4 should be expected 
between pH 9 and 14, while maintaining a molar ratio of Fe3+:Fe2+ is 2:1 under a non-
oxidizing oxygen free environment (Cornell & Schwertmann, 2003).  
Magnetite NPs are not also very stable under ambient conditions, and are easily oxidized to 
maghemite or dissolved in an acidic medium. Since maghemite is a ferrimagnet, oxidation is 
the minor problem. Therefore, magnetite particles can be subjected to deliberate oxidation to 
convert them into maghemite. This transformation is achieved by dispersing them in acidic 
medium, then addition of iron(III) nitrate. The maghemite particles obtained are then 
chemically stable in alkaline and acidic medium. However, even if the magnetite particles 
are converted into maghemite after their initial formation, the experimental challenge in the 
synthesis of MNPs by co-precipitation lies in control of the particle size and thus achieving a 
narrow particle size distribution. 
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Nanoparticle characteristics 
Size Reaction Synthetic 
method 
Range Distribution
Shape 
control
Synthesis 
Temperature Time Yield 
Surface-
capping 
agents 
Aerosol/vapor 
(pyrolisys) 
5-60 
nm 
Broad Good 
Complicated, 
vacuum/ 
controlled 
atmosphere 
High/ 
very high 
Minutes
/hours 
Medium 
Needed, 
after 
reaction 
Gas deposition 
5-50 
nm 
Narrow Good 
Complicated, 
vacuum/ 
controlled 
atmosphere 
Very high Minutes
High/ 
scalable 
Needed, 
after 
reaction 
Sol-gel 
3-150 
nm 
Narrow/ 
broad 
Good Simple 20-90 °C 
Hours/ 
days 
Medium 
Needed, 
during 
reaction 
Co-precipitation 
10-50 
nm 
Broad/ 
narrow 
Poor Very simple 20-90 °C Minutes
High/ 
scalable 
Needed, 
during 
reaction 
Thermal 
decomposition 
2-20 
nm 
Very narrow
Very 
good 
Complicated, 
inert atmosphere
100-330 °C Hours 
High/ 
scalable 
Needed, 
during 
reaction 
Microemulsion 
4-15 
nm 
Narrow Good Complicated 20-70 °C 
Hours/ 
days 
Low 
Needed, 
during 
reaction 
Hydrothermal 
10-150 
nm 
Narrow 
Very 
good 
Simple, high 
pressure 
100 °C -high 
Hours/ 
days 
Medium 
Needed, 
during 
reaction 
Table 1. Comparison of different synthetic methods to produce MNPs. 
Particles prepared by co-precipitation unfortunately tend to be rather polydisperse as 
indicated in the Fig. 1a. It is well known that a short burst of nucleation and subsequent 
slowly controlled growth is crucial to produce monodisperse particles. Controlling these 
processes is therefore the key in the production of monodisperse iron oxide MNPs. In order 
to prevent them from possible oxidation in air as well as from NPs agglomeration, co-
precipitated NPs are usually coated with organic or inorganic molecules during the 
precipitation process. Recently, significant advances in preparing monodisperse magnetite 
NPs, of different sizes, have been made by the use of organic additives as stabilizing and/or 
reducing agents. The NP preparation can be achieved in presence of stabilizing agents such 
as dextran, polyvinyl alcohol, citrate, polyethyleneimine, block copolymers, and using 
various silane-based chemistry (Majewski & Thierry, 2007). Recent studies also showed that 
oleic acid is the best candidate for the stabilization of Fe3O4 (Cushing et al., 2004; Willis et al., 
2005). The effect of organic ions on the formation of metal oxides or oxyhydroxides can be 
rationalized by two competing mechanisms. Chelation of the metal ions can prevent 
nucleation and lead to the formation of larger particles because the number of nuclei formed 
is small and the system is dominated by particle growth. However, the adsorption of 
additives on the nuclei and the growing crystals may inhibit the growth of the particles, 
which favors the formation of small units. 
On the other hand, better control over size, monodispersity and shape can be achieved using 
emulsions, microemulsion (μe) or nanoemulsion (ne) systems (water-in-oil or oil-in-water) 
that provide a confined environment during nucleation and growth of the iron oxide NPs 
(Gupta & Wells, 2004). In practice, however, little control can actually be driven over the size 
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and size distribution of the nanostructures and, moreover, only small quantities of iron 
oxide can be obtained, owing to the constraints of low reagent amount required by this 
synthetic procedure. A μe is defined as a thermodynamically stable isotropic dispersion of 
two immiscible liquids, since the microdomain of either or both liquids has been stabilized 
by an interfacial film of surface-active agents. In water-in-oil μe, the aqueous phase is 
dispersed as microdroplets (typically 1–50 nm in size) surrounded by a monolayer of 
surfactant molecules in the continuous hydrocarbon phase. The size of the reverse micelle is 
determined by the molar ratio of water to surfactant. When a soluble metal salt is 
incorporated in the aqueous phase of the μe, it will remain in the aqueous microdroplets 
surrounded by oil. By mixing two identical water-in-oil μe containing the desired reactants, 
these microdroplets will continuously collide, coalesce, and break again (Malheiro et al., 
2007). By the addition of solvent, such as acetone or ethanol to the μe, the precipitate can be 
extracted by filtering or centrifuging the mixture. In this sense, a μe can be used as a 
nanoreactor for the formation of NPs. Using the μe technique, metallic NPs and alloys (Co, 
Fe, FeCo, FePt, CoPt, etc.) or magnetic oxide such as iron oxide or spinel ferrites, MFe2O4 (M: 
Mn, Co, Ni, Cu, Zn, Mg, or Cd, etc.) have been synthesized in reverse micelles (water in oil 
systems) by using many different surfactants and co-surfactants molecules (O'Connor et al., 
1999). Co-surfactant molecules, generally an alcohol with small chain, have an important 
role in the reverse micelle structure formation increasing the molecules density onto the μe 
threshold and avoiding the metallic cations percolation (Malheiro et al., 2007). For example, 
highly monodispersed iron oxide NPs were synthesized by using the aqueous core of 
aerosol-OT (AOT)/n-hexane reverse micelles (w/o μe) as showed in Fig. 1b. The reverse 
micelles have aqueous inner core, which can dissolve hydrophilic compounds, salts, etc. A 
deoxygenated aqueous solution of the Fe3+ and Fe2+ salts (molar ratio 2:1) was dissolved in 
the aqueous core of the reverse micelles formed by AOT in n-hexane. Chemical precipitation 
was achieved by using a deoxygenated solution of sodium hydroxide. Smaller and more 
uniform particles were prepared by precipitation of magnetite at low temperature in the 
presence of nitrogen gas. As described in the conventionally μe preparation methods, two 
identical μe systems are mixed and coalesced. During coalescence stage, the microdroplet 
size was continuously varying while the aqueous solution mixture becomes reacting and the 
initial nucleation step took place. Thus, although many types of MNPs have been 
synthesized in a controlled manner using the μe method, the particle size and shapes usually 
vary over a relative wide range. This problem have been solved by using a cation-
substituted surfactant molecules in which the polar head containing the desired cation and 
the aqueous solution was formed by second reactant, such as the alkaline. In this way, the 
coalescence stage is avoided and the microdroplet size control is more effective. Moreover, 
the working window for the synthesis in μe is usually quite narrow and the yield of NPs is 
low compared to other methods, such as thermal decomposition and co-precipitation. Large 
amounts of solvent are necessary to synthesize appreciable amounts of material. It is thus 
not a very feasible process and also rather difficult to scale-up.  
Inspired by the synthesis of high-quality semiconductor nanocrystals and oxides in non-
aqueous media by thermal decomposition (Lu et al., 2007; O'Brien et al., 2001), the most 
promising method for the synthesis of MNPs with control over size and shape have been 
developed to date. Monodisperse magnetic nanocrystals with smaller size can essentially be 
synthesized through the thermal decomposition of organometallic compounds in high-
boiling organic solvents containing stabilizing surfactants with long chain carboxylic acids 
and amines (Hyeon, 2003a; Sun et al., 2000; Varanda & Jafelicci, 2006). The organometallic 
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precursors include metal acetylacetonates, metal cupferronates or carbonyls. The reagent 
proportions, reaction temperature, reaction time, as well as aging period are crucial for the 
precise control of size and morphology. If the metal in the precursor is zero-valent, such as 
in carbonyls, thermal decomposition initially leads to formation of the metal, but two-step 
procedures can be used to produce oxide NPs. For instance, iron pentacarbonyl can be 
decomposed in a mixture of octylether and oleic acid with subsequent addition of 
trimethylamine oxide (CH3)3NO as a mild oxidant at elevated temperature, results in 
formation of monodisperse γ-Fe2O3 nanocrystals with a size of approximately 13 nm (Hyeon 
et al., 2001). Decomposition of precursors with cationic metal centers leads directly to the 
oxides, that is, to Fe3O4, if [Fe(acac)3] is decomposed in the presence of 1,2- hexadecanediol, 
oleylamine, and oleic acid in phenylether, as showed in Fig. 1c. The size and shape of the 
nanocrystals could be controlled by variation of the reactivity and concentration of the 
precursors. The reactivity was tuned by changing the chain length and concentration of the 
surfactants. Generally, the shorter the chain length, the faster the reaction rate is. Alcohols or 
primary amines could be used to accelerate the reaction rate and lower the reaction 
temperature. Hyeon et al. (Park et al., 2004) have also used a similar thermal decomposition 
approach for the preparation of monodisperse iron oxide NPs. They used nontoxic and 
inexpensive iron(III) chloride and sodium oleate to generate an iron oleate complex in situ 
which was then decomposed at high temperatures in different solvents, such as 1-
hexadecene, octylether, 1-octadecene, 1-eicosene, or trioctylamine. Particle sizes are in the 
range of 5–22 nm, depending on the decomposition temperature and aging period. The NPs 
obtained are dispersible in various organic solvents including hexane and toluene. 
However, water soluble MNPs are more desirable for applications in biotechnology. For that 
purpose, a very simple synthesis of water-soluble magnetite NPs was reported recently. 
Using FeCl3·6H2O as iron source and 2-pyrrolidone as coordinating solvent, water soluble 
Fe3O4 nanocrystals were prepared under reflux (245 °C) (Li et al., 2005). The mean particles 
size can be controlled at 4, 12, and 60 nm, respectively, when the reflux time is 1, 10, and 24 
h. With increasing reflux time, the shapes of the particles changed from spherical at early 
stage to cubic morphologies for longer times. More recently, the same group developed a 
one-pot synthesis of water-soluble magnetite NPs prepared under similar reaction 
conditions by the addition of a dicarboxyl-terminated poly(ethylene glycol) as a surface 
capping agent (Hu et al., 2006). These NPs can potentially be used as magnetic resonance 
imaging contrast agents for cancer diagnosis. The thermal decomposition method is also 
used to prepare metallic NPs (Varanda et al., 2007; Varanda & Jafelicci, 2006). The advantage 
of metallic NPs is their larger magnetization compared to metal oxides. Metallic iron, cobalt, 
nickel and alloys such as FePt (Fig. 1d), CoPt, NiPt, and CrPt or using Ru instead Pt in the 
alloys NPs were synthesized by thermal decomposition of different metallic precursors in a 
varied of solvents. Magnetic alloys have many advantages, such as high magnetic 
anisotropy, enhanced magnetic susceptibility, and large coercivities. Beside CoPt3 and FePt, 
metal phosphides are currently of great scientific interest in materials science and chemistry. 
For example, hexagonal iron phosphide and related materials have been intensively studied 
for their ferromagnetism, magnetoresistance, and magnetocaloric effects (Luo et al., 2004). In 
addition, the thermal decomposition method can be used to synthesized antiferromagnetic 
NPs such as MnO (Fig. 1e) and FeO which have been waking is very interesting due to 
potential application in MRI as water relaxation time T2 interfering. Due to their versatility, 
the thermal decomposition method has been also combining with the seed-mediated growth 
methodology in order to synthesis core-shell nanosctrutuctured NPs such as Fe3O4-coated 
FePt (FePt@Fe3O4, Fig. 1f) (Varanda et al., 2008).  
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Fig. 1. TEM of MNPs prepared using different synthetic routes: above, magnetite 
synthesized by (a) co-precipitation, (b) microemulsion, and (c) thermal decomposition; 
bellow, (d) FePt, (e) MnO, and (f) FePt@Fe3O4 synthesized by thermal decomposition.  
4. Surface engineering 
The functionalization of NP surface is one method for tuning the overall properties of 
particles to fit targeted applications. The surface modification of NPs by functional 
molecules/particles/polymers has different tasks to fulfill (de Dios & Díaz-Garcia, 2010): 
a. stabilize the NPs in solution to control the growth of the embryonic particles and 
determine their shape during the growth process; 
b. provide functional groups at the surface for further derivatization; 
c. enhance NP solubilization in various solvents extending their application possibilities; 
d. capping layers can modify the electronic, optical, magnetic and chemical properties of 
the particles, providing a plethora of controllable nanotools; 
e. modify the capability to assemble the particles in specific arrays or the ability to target 
desired chemical, physical, or biological environments; 
f. improve mechanical and chemical performances of the NP surface, e.g. passivation; 
g. in some instances a reduction of their toxicity is achieved. 
Colloidal nanostructures dispersed in a medium collide with each other frequently and the 
overall colloidal stability of the dispersion, which is critical to most potential NP 
applications, is dictated by the fate of the individual particles after each collision (Hunter, 
2001). Attractive interactions leads to irreversible aggregation of the NPs, and in the case of 
magnetite particles, magnetic dipole-dipole interactions can provide an additional attractive 
force. A critical requirement is therefore to surface-engineer the NPs with (macro) molecules 
that provide repulsive forces large enough to counter the attractive ones in the collision 
processes. Repulsive forces can be achieved in the presence of an electrical double layer on 
the particles (electrostatic stabilization) or in presence of polymeric chains providing steric 
stabilization. Attractive van der Waals and repulsive Coulombian forces are strongly 
influenced by the dispersion medium properties. Colloidal stability of NP dispersion must 
therefore be considered for a specific system, especially in the setting of bio-applications that 
require colloidal stability in complex biological medium such as blood or plasma. Steric 
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stabilization provided by adsorption or grafting of polymers on the NPs is the most efficient 
way to prevent aggregation in bio-systems (Majewski & Thierry, 2007).  
Biomedical applications often require stringent control of the NPs bio-interfaces. Along with 
the need for colloidal stability in complex biological environment, a major requirement for 
the successful integration of MNPs in biomedical application is indeed to minimize 
biologically non-specific adsorption events, for example, the adsorption of plasma proteins 
on the NP surfaces. Such non-specific events can drastically hamper molecular recognition 
processes at the surface of the NPs, therefore reducing the efficiency of MNP-based bio-
assays. A pre-requisite to the widespread use of NPs in vivo is also their ability to resist non-
specific adsorption of opsonins. Opsonization of NPs by plasma proteins results into rapid 
elimination from the blood by the mononuclear phagocyte system (MPS) with consequent 
accumulation in organs of the reticuloendothelial system (RES, phagocytic cells residing in 
tissues forming party of the body immune system) such as spleen and liver. The nature (e.g., 
complement proteins and immunoglobulins) and amount of plasma proteins adsorbing on 
NPs is directly related to the physicochemical characteristics of the NPs surfaces. Adsorbed 
opsonins potentially lead to specific interactions with receptors on the surface of 
macrophages and hepatocytes and the subsequent elimination of the NPs (Vonarbourg et 
al., 2006; Yan et al., 2005). For instance, concerning NP sizes, for example, the overall particle 
size must be small enough to evade uptake by the RES, but large enough to avoid renal 
clearance. Procedures to achieve high quality bio-interfaces able to resist non-specific 
interaction have been implemented on macroscopic surfaces. It is commonly admitted that 
non-fouling surfaces should posses the following characteristic: (1) hydrophilic, (2) 
hydrogen bond acceptors, (3) no hydrogen bond donors, (4) neutral. In summary, colloidal 
electrostatic stabilization arising from repulsion of surface charges on the NPs is typically 
not adequate to prevent aggregation in biological solutions due to the presence of salts or 
other electrolytes that may neutralize this charge. Furthermore, upon intravenous injection 
the surfaces of MNPs are subjected to adsorption of plasma protein, or opsonization, as the 
first step in their clearance by the RES. Evading uptake by the RES and maintaining a long 
plasma half-life is a major challenge for many MNP applications in medicine (Berry & 
Curtis, 2003; Sun et al., 2008). In order to minimize these critical effects, besides other 
considerations such as toxicity, biodistribution, and blood circulation time (see Section 7), 
many coating process have been used to modify/functionalize the NP surfaces, that provide 
a biocompatible surface, and after properly derivatization with targeting ligands, a bio-
selectable surface for an specific body tissue, as schematically represented in the Fig. 2.  
4.1 Polymeric coatings 
Polymeric coatings provide a steric barrier to prevent NP agglomeration and avoid 
opsonization. These coatings also provide a means to tailor the surface properties of MNPs 
such as surface charge and chemical functionality. Some critical aspects with regard to 
polymeric coatings may affect the MNP performance including nature of the polymer 
chemical structure (e.g. hydrophilicity/hydrophobicity, biodegradation characteristics, etc.), 
the length or molecular weight of the polymer, the manner in which the polymer is 
anchored or attached (e.g. electrostatic or covalent bonding), the conformation of the 
polymer, and the degree of particle surface coverage. Various monomeric species, such as 
bisphosphonates, dimercaptosuccinic acid, and alkoxysilanes, have been evaluated as 
anchors to facilitate attachment of polymer coatings on MNPs (Sun et al., 2008). 
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Fig. 2. Representative MNPs surface engineering coating process using polymer, surfactant, 
liposome, and inorganic salt (core-shell nanostructure) followed by derivatization surface 
with targeting ligands (biocompatible and biosselective MNPs for biomedical applications).  
The molecular weight and geometric orientation of the polymer on the surface of the 
particles in the form of loops, trains, and tails or as end-grafted brushes or as fully 
encapsulated polymer shells not only affect the antifouling characteristics of the NP, but also 
contribute to their effective hydrodynamic size, which is another key factor in avoiding 
recognition by the RES. A variety of natural and synthetic polymers have been evaluated for 
use as coatings on MNPs. Readers are directed to several reviews on the topic for a 
comprehensive analysis of these materials (Gupta et al., 2007; Gupta & Gupta, 2005). In this 
section the most widely utilized and successful polymer coating for in vivo applications will 
be emphasized. Among several nature and synthetic polymers used as coating in MNPs for 
biomedical applications, many monomers due to systematic uses can be mentioned: (a) 
dextran, biocompatible and biodegradable, may be administered by an intravenous or oral 
route and used to stabilizer the colloidal solution and enhancer the blood circulation time 
(Massia et al., 2000). Dextran coatings can be achieved directly during the preparation of 
magnetite NPs in the co-precipitation technique but also by conjugating reactive dextran, for 
example, carboxymethyl dextran and partially oxidized dextran (via formation of Schiff’s 
bases linkages), onto functionalized NPs. The nature of the dextran derivative, the number 
of reactive groups and immobilization conditions (e.g., ionic strength, pH) can be used to 
control the final polymer conformation on the surfaces (Majewski & Thierry, 2007). As 
mentioned earlier, an issue when working with NPs is to avoid irreversible aggregation 
during coating procedures subsequent to synthesis. Optimizing experimental conjugation 
conditions, monodisperse carboxymethyl dextran-coated monocrystalline magnetite NPs 
prepared by microemulsion methodology have been prepared without detectable 
aggregation; (b) poly(ethylene glycol), PEG, is another widely used polymer for NP coating 
owing to its hydrophilicity and no-antigenic and no-immunogenic properties (Brus et al., 
2004; Gupta et al., 2007). The antifouling nature of PEG has been shown to reduce NP 
uptake by macrophages and extend blood circulation time in vivo. Various methods have 
been utilized to attach PEG to MNPs including silane grafting to oxide surfaces, 
polymerization at the surface of MNPs, and modification through sol–gel approaches 
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(Gupta et al., 2007). To control polymer conformation and provide stable covalent linkages 
to the surface of iron oxide NPs, Kohler et al. developed bifunctional PEG silanes capable of 
forming self-assembled monolayers (SAMs) and increasing the packing density of the 
polymer chains onto the NPs surface (Kohler et al., 2004; Zhang et al., 2002). In addition, 
terminal amine or carboxyl groups extending out from the NP surface provide sites for 
conjugation of functional ligands, as demonstrated by the attachment of folic acid. The 
strong attachment of the PEG molecules not only improved the steric stabilization of the 
MNPs in vivo against interactions with opsonins and cells, but also imparts the prolonged 
circulation in blood and reduced RES uptake (Gupta & Curtis, 2004; Gupta & Wells, 2004). 
In addition, PEG-coated MNPs are hugely internalized by cells, presumably owing to the 
fluid phase endocytosis mechanism, probably their high solubility in cell membranes, since 
it is an amphiphilic molecule; (c) polyvinyl alcohol (PVA) is used to prevent agglomeration 
and enhancing the colloidal stability (Xue & Sun, 2001); (d) polyacrylic acid (PAA) increase 
the stability and biocompatibility of the NP and also helps in bioadhesion (Burugapalli et al., 
2004). Another consideration to take into account while utilizing polymer coatings is their 
effects on the NP magnetic properties, where the saturation magnetization generally 
decreases with the thickness polymer coating increases (Mikhaylova et al., 2004). 
4.2 Non-polymeric stabilizers (surfactants) 
Surfactants or polymers are often employed to passivate the surface of the NPs during or 
after the synthesis to avoid agglomeration. In general, electrostatic repulsion or steric 
repulsion can be used to disperse NPs and keep them in a stable colloidal state. In the case 
of ferrofluids, the surface properties of the magnetic particles are the main factors 
determining colloidal stability. The major measures used to enhance the stability of 
ferrofluids are the control of surface charge and the use of specific surfactants (Lu et al., 
2007). For instance, magnetite NPs synthesized through the co-precipitation of Fe2+ and Fe3+ 
in ammonia or NaOH solution are usually negatively charged, resulting in agglomeration. 
In general, surfactants can be chemically anchored or physically adsorbed on MNPs to form 
a single or double layer which creates repulsive (mainly as steric repulsion) forces to balance 
the magnetic and the van der Waals attractive forces acting on the NPs. Thus, by steric 
repulsion, the magnetic particles are stabilized in suspension. Additionally, in order to 
stabilize the colloidal dispersion, Gedanken et al. studied the adsorption of alkanesulphonic 
and alkanephosphonic acids on the surfaces of amorphous Fe2O3 NPs and proposed two 
possible bonding schemes for the phosphonate ions on Fe3+, i.e., one O or two O atoms of 
the phosphonate groups binding onto the surface (Yee et al., 1999). Sahoo et al. have reported 
the surface derivatization of magnetite by oleic acid, lauric acid, dodecylphosphonic acid, 
hexadecylphosphonic acid, dihexadecylphosphonic acid etc. to stabilize the NPs in organic 
solvents (Sahoo et al., 2001). They found that alkyl phosphonates and phosphates could be 
used for obtaining thermodynamically stable dispersions of MNPs. The authors suggested 
on the basis of the results obtained from the temperature and enthalpy desorption studies 
that these ligands form a quasi-bilayer structure with the primary layer strongly bonded to 
the surface of NPs. The ferrofluids, frequently dispersed in hexadecane as the carrier 
medium, may be stabilized by various long-chain surfactants, the classic example being oleic 
acid, which has a C18 (oleic) tail with a cis-double-bond in the middle, forming a kink. Such 
kinks have been postulated as necessary for effective stabilization, and indeed stearic acid, 
with no double-bond in its C18 (stearic) tail, cannot stabilize ferrofluid suspensions (Gupta 
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& Gupta, 2005). The long chain surfactants uses such as oleic acid and oleylamine, generally 
employed in the thermal decomposition synthesis, leads too much stabilized NPs 
suspension in organic media (e.g. hexane), but is desired water stabilized NPs suspension 
for biomedical applications. In this cases, ligand exchanges or coating with water compatible 
molecules/compounds can be use to stabilizer these NPs in water suspension instead 
organic solvents. Because use of polymers leads to thick surface layers, Portet et al. have 
(Portet et al., 2001) developed monomeric organic molecules as coating materials. The main 
property of these small molecules is to produce a homogeneous coating of the entire iron 
oxide core that is able to inhibit the protein absorption. Phosphorylcholine (PC)-derived 
polymers are known to protect prosthesis against protein contamination, but pure PC 
coatings do not allow colloidal stability at physiological pH (Denizot et al., 1999).  
4.3 Liposomes and micelles 
The development of liposomes as drug delivery vehicles can be considered one of the 
earliest forms of nanomedicine recently developed. These phospholipid bi-layered 
membrane vesicles, as indicated in the Fig. 2, can range from100 nm up to 5 μm in size and 
have been utilized for the delivery of small molecules, proteins and peptides, DNA, and MR 
imaging contrast agents (Sun et al., 2008; Torchilin, 2005). An advantage of liposome 
encapsulation or micelar nanoparticle environment (MNE) is that it in vivo behavior already 
has been well established with processes such as PEGylation resulting in long circulation 
times. Another favorable feature of liposomes is the ability to encapsulate a large number of 
MNP cores and deliver them together, avoiding dilution, to a target site. Combining a 
therapeutic agent in the payload further enhances the multifunctionality of these delivery 
vehicles. Magnetic fluid-loaded liposomes (MFLs) with hydrodynamic size of 195±33 nm 
were formed by film hydration coupled with sequential extrusion and were capable of 
encapsulating up to 1.67 mol of iron per mol of lipid. In vivo evaluation in mice using MR 
angiography demonstrated that these MFLs were still present in the blood 24 h after 
intravenous injection confirming their long circulating behavior. Similarly, multifunctional 
micelles formed with amphiphilic block copolymers have also been used to entrap MNPs 
for these applications (Sutton et al., 2007). Many micelar system mainly based on the 
phospholipid or phospholipid-derivated have been studying in order their potential 
application in drug delivery system and, in addition, their biocompatible properties has 
used as coating system in order to promote the MNP increases blood circulation, 
biodistribution and cell membrane internalization. 
4.4 Inorganic coating (core-shell nanostructure) 
In addition to organic coatings, core–shell structures utilizing biocompatible silica, gold or 
other noble metal, carbon, etc., to encapsulate the MNPs have become another attractive 
approach for developing MNPs for biomedical applications. These NPs have inner iron 
oxide/alloys magnetic core with an outer metallic shell of inorganic materials. These inert 
coatings, or shells, provide not only the stability to the NPs in solution but also protection 
against chemical degradation of magnetic cores, prevent the release of potentially toxic 
components, and helps in binging the many biological ligands at the NP surface since that 
functionalization chemistries are generally better established with these materials than those 
that comprise MNPs. Silica shells are attractive options to serve as protective coatings on 
MNPs due to their stability under aqueous conditions and ease of synthesis. An advantage 
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of having a surface enriched in silica is the presence of surface silanol groups that can easily 
react with alcohols and silane coupling agents to produce dispersions that are not only 
stable in non-aqueous solvents but also provide the ideal anchorage for covalent bounding 
of specific ligands. The strong binding makes desorption of these ligands a difficult task. In 
addition, the silica surface confers high stability to suspensions of the particles at high 
volume fractions, changes in pH or electrolyte concentration (Gupta & Gupta, 2005). Thus, a 
silica shell does not only protect the magnetic core, but can also prevent the direct contact of 
the core with additional agents linked to the silica surface avoiding unwanted interactions. 
Sol–gel processes using tetraethoxysilane (TEOS) are generally utilized throughout the 
literature to produce coatings of controlled thickness (Lu et al., 2002). The use of functional 
alkoxysilanes, such as 3-aminopropyltriethyoxysilane (APS), allows for surface reactive 
groups to be easily added to these core–shell structures. In addition, the ability to 
encapsulate functional molecules, such as alternative imaging or therapeutic agents, within 
this protective matrix is a unique feature to these nanostructures (Tada et al., 2007).  
The Stöber method and sol–gel processes are the prevailing choices for coating MNPs with 
silica. The coating thickness can be tuned by varying the concentration of ammonium and 
the ratio of TEOS to H2O. The functionalization could introduce additional functionality, so 
that the magnetic particles are potentially of use in biolabeling, drug targeting, and drug 
delivery. In previous studies involving the coating of hematite spindles and much smaller 
magnetite clusters with silica, the iron oxide cores could subsequently be reduced in the dry 
state to metallic iron (Varanda et al., 2002a; Varanda et al., 2001). The advantage of this 
method is that silica coating was performed on an oxide surface, which easily binds to silica 
through OH surface groups. Since the iron oxide surface has a strong affinity towards silica, 
no primer was required to promote the deposition and adhesion of silica. Owing to the 
negative charges on the silica shells, these coated MNPs are re-dispersible in water without 
the need of adding other surfactants. Though great progress in the field of silica-coated NPs 
has been made, the synthesis of uniform silica shells with controlled thickness on the 
nanometer scale still remains challenging. As an alternative, the microemulsion method was 
also tried resulting in a best silica thickness control. Although metals protected by silica can 
be synthesized by reduction after synthesis, silica deposition directly on pure metal particles 
is more complicated because of the lack of OH groups on the metal surface. An additional 
difficulty for coating metallic NPs, such as iron and cobalt with silica, which has to be 
overcome, is that iron and cobalt are readily oxidized in the presence of dissolved oxygen. 
Therefore, it is necessary to use a primer to make the surface “vitreophilic” (glasslike), such 
as coat precious metals or realize the metal surface passivation by the gentle oxidation as 
starting materials for such silica coating. From the mentioned examples above, it can be seen 
that silica coating of magnetic oxide NPs is a fairly controllable process. However, silica is 
unstable under basic condition, in addition, silica may contain pores through which oxygen 
or other species could diffuse. Coating with other oxides is much less developed and 
therefore alternative methods, especially those which would allow stabilization under 
alkaline conditions, are needed. Gold offers several advantages as a coating material for 
MNPs due to its low chemical reactivity and unique ability to form self-assembled 
monolayers (SAMs) on their surface using alkanethiols (Sun et al., 2008). Unfortunately, this 
chemical inertness may also lead to difficulty in forming gold shells over MNPs. Recent 
advances in synthesizing gold-coated iron NPs through a variety of methods ranging from 
reversed microemulsion, combined wet chemical, to laser irradiation, redox transmetalation, 
iterative hydroxylamine seeding, have been reviewed by Lu et al. (Lu et al., 2007). Gold 
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coating of MNPs is especially interesting, since the gold surface can be further 
functionalized with thiol groups. This treatment allows the linkage of functional ligands 
which may make the materials suitable for catalytic and optical applications. Although to 
date most studies have focused on the development of polymer or silica protective coatings, 
recently carbon-protected MNPs are receiving more attention, because carbon-based 
materials have many advantages over polymer or silica, such as much higher chemical and 
thermal stability as well as biocompatibility. Since then, many studies have shown that in 
the presence of metal NPs, graphitized carbon structures, such as carbon nanotubes and 
carbon onions, are formed under arc-discharge, laser ablation, and electron irradiation. The 
well-developed graphitic carbon layers provide an effective barrier against oxidation and 
acid erosion. These facts indicate that it is possible to synthesize carbon-coated MNPs, 
which are thermally stabile and have high stability against oxidation and acid leaching, 
which is crucial for some applications (Lu et al., 2007). 
5. Multifunctional magnetic nanoparticles 
Despite the potential benefits that MNPs have rendered to biomedicine, some applications 
remains challenging, for instance, in vivo real-time monitoring of cellular events, specific 
targeting to the action site or efficient drug delivery inside the target cell. In this context, the 
design of multifunctional NPs could significantly improve already existing NPs 
characteristics and help to surmount these challengers. Whereas a monofunctional NP 
provide a single function, i.e. a liposome can transport drugs but does not have the inherent 
property to distinguish between healthy and unhealthy cells or tissues, a multifunctional 
NPs combine different functionalities in a single stable construct. For example, a core 
particle could be linked to a specific targeting function that recognizes the unique surface 
signatures of their target cells. Simultaneously, the same particle can be modified with an 
imaging agent to monitor the drug transport process, a function to evaluate the therapeutic 
efficacy of a drug, a specific cellular penetration moiety and a therapeutic agent (Sanvicens 
& Marco, 2008). Thus, the fabrication of bifunctional or multifunctional NPs has received a 
great deal of attention in recent years. Hybrid inorganic NPs are emerging as useful probes 
for magnetic-based targeting, delivery, cell separation, MRI, and fluorescence-based 
biolabeling applications. Gold (Au) NPs have been extensively used to prepare 
multifunctional composites with quantum dots (QDs) and MNPs. Typical examples include 
Fe3O4-Au (Yu et al., 2005), CdSe-Au (Mokari et al., 2004), and PbSe-Au-Fe3O4 (Shi et al., 
2006). Multifunctional NPs have been actively explored for the enhancement of imaging, 
targeting, and delivery. In the field of biological and biomedical imaging, QDs and MNPs 
have been enjoying greater roles in biolabeling and MRI respectively. A combination of 
optical and magnetic properties in a single material would enable simultaneous 
biolabeling/imaging and cell sorting/separation. Nanocomposites consisting of 
semiconductor and MNPs, known as magnetic quantum dots (MQDs) or luminomagnetic 
nanoparticles (LMNPs) (Sun et al., 2008), are of great interest as a new class of materials 
(Selvan et al., 2010). Despite all of these advances, the application of multifunctional NPs in 
in vivo imaging is still in its infancy. As discussed throughout this Chapter, the ability to add 
components to MNPs in a modular fashion allows for specific features and functional 
moieties to be interchanged or combined. Ligands such as targeting agents, permeation 
enhancers, optical dyes, and therapeutic agents can all be conjugated on the surface or 
incorporated within these nanostructures (Fig. 3, left).  
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Fig. 3. (left) Targeting, therapeutic, luminescent and biocompatibility agents on the same NP 
surface enabling multifunctionality in a single MFMNP; (right, adapted from (Corr et al., 
2008) Many different types of LMNPs according to their preparation route. 
To perform such nanoscale engineering, bioconjugation chemistries and techniques utilized 
for protein coupling have been studied (Sun et al., 2008). Techniques such as avidin–biotin 
binding, use of heterobifunctional linkers to form amide, ester, or disulfide bonds, and more 
recently “click” chemistries (Nandivada et al., 2007), have all been shown to be useful in 
attaching functional ligands to MNPs. In addition to understanding the mechanisms of these 
reactions, those utilizing these techniques on MNPs may also find it useful to review basic 
concepts of colloidal science to avoid unwanted NP flocculation or aggregation (Hunter, 
2001). One example of adding functionality to MNPs has been the combination of organic 
dyes or fluorophores as optical agents allowing detection by multiple imaging modalities.  
Both magnetic and fluorescent inorganic NPs have been shown to play a significant role in 
nanotechnology. Just looking at the wealth of possible applications open to magnetic and 
fluorescent materials, it is not hard to see why the combination of these two entities opens 
up the opportunity to provide new nanocomposites which could act as multi-targeting, 
multi-functional and multi-treating tools. It is expected that the combination of magnetic 
and fluorescent properties in one nanocomposite would open up great prospects both in 
nano- and biotechnology, enabling the engineering of unique targeted, nanoscale photonic 
devices which could be manipulated using an external magnetic field. The combination of a 
magnetic and a fluorescent entity in a new bimodal ‘‘two-in-one’’ LMNP may provide a new 
multifunctional nanomaterial with a broad range of potential applications. First of all, 
multimodal magnetic-fluorescent assays would be very beneficial for in vitro and in vivo bio-
imaging applications such as MRI and fluorescence microscopy. Second of all, these 
nanocomposites can be utilized as agents in nanomedicine. For example, one of their most 
promising applications is a bimodal anticancer therapy, encompassing photodynamic and 
hyperthermic capabilities. LMNPs can also serve as an all-in-one diagnostic and therapeutic 
tool, which could be used, for example, to visualize and simultaneously treat various 
diseases. Another exciting application of LMNPs is in cell tracking, cytometry and magnetic 
separation, which could be easily controlled and monitored using fluorescent microscopy. A 
specific difficulty in the preparation of two-in-one LMNPs is the risk of quenching of the 
fluorophore on the surface of the particle by the magnetic core. In addition, if there are a 
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number of fluorescent molecules attached to the surface of the particle, they may act to 
quench each other. The problem of quenching can be partially resolved by providing the 
MNP with a stable shell prior to the introduction of the fluorescent molecule, or by first 
treating the fluorophore with an appropriate spacer. Finally there are typical problems 
related to instability and aggregation of the nanocomposites in solutions. Therefore, a 
careful design and an extremely accurate synthesis methodology are required for the 
development of the LMNPs to avoid their aggregation and precipitation in comparison to 
the developed techniques used in the case of MNPs. Most of these nanocomposites are core-
shell nanostructures. In general, we can identify eight main types of LMNPs (Fig. 3, right) 
(Corr et al., 2008). Recently, the conjugation of near-infrared fluorescent (NIRF) dyes to 
MNPs has received significant attention due to the deep penetration of NIRF light through 
tissues. The integration of NIRF detectability may allow for these NPs to be used for both 
presurgical planning by MRI and intraoperative resection of malignant tissues by optical 
imaging. Since both MRI and optical signals come from the same NPs, the MR image can 
serve as a roadmap to the fluorescently labeled tumor cells (Sun et al., 2008).  
6. Biomedical applications of nanomagnetics 
6.1 Magnetic resonance imaging - MRI 
MRI is one of the most powerful imaging techniques for living organisms as it provides 
images with excellent anatomical details based on soft-tissue contrast and functional 
information in a non-invasive and real-time monitoring manner. MRI has further advanced 
by the development of contrast agents that enable more specific and clearer images and 
enlargements of detectable organs and systems, leading to a wide scope of applications of 
MRI not only for diagnostic radiology but also for therapeutic medicine. Current MRI 
contrast agents are in the form of either paramagnetic complexes or MNPs. Paramagnetic 
complexes, which are usually gadolinium (Gd3+) or manganese (Mn2+) chelates, accelerate 
longitudinal (T1) relaxation of water protons and exert bright contrast in regions where the 
complexes localize. For instance, gadolinium diethylenetriamine pentaacetate (Gd-DTPA) 
has been the most widely used of such complexes and its main clinical applications are 
focused on detecting the breakage of the blood-brain barrier (BBB) and changes in 
vascularity, flow dynamics, and perfusion (Na et al., 2007; Weinmann et al., 2003). Iron 
oxide NPs were the first, and are the most commonly used MNP-based contrast agents for 
MRI. Importantly, it have been taken through regulatory approval and may be safety, and 
legally, used in human (Pankhurst et al., 2009). The limitations of using MNPs, however, are 
that millions of particle with very high saturation magnetization values are required to 
achieve sufficient contrast (Gupta et al., 2007). The efficacy, as MRI contrast agent, of iron 
oxide NPs depends to a large extent on their physicochemical properties, particularly their 
size and surface chemistry, the later properly bioconjugated with targeting agents. The spin-
spin relaxation time (T2) depends of the MNP size and larger particles exhibit larger T2 effect 
(Bin Na et al., 2007). In addition, the intrinsic magnetization of the particles is also important 
and metallic or alloys NPs are preferable than iron oxides concerning the Ms of these latter. 
In this context, cobalt NPs present much higher room temperature Ms than those iron 
oxides, which could be resulting in a larger effect on proton relaxation giving improved MRI 
contrast and allowing smaller MNPs core use without compromising sensitivity. However, 
water-soluble Co NPs is very difficult to obtain and stabilizer, besides their high toxicity 
intrinsic to the metal NPs. As observed with Co, Fe and FePt NPs present advantage 
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compared with the oxide for enhanced MRI contrast, but their potential uses require further 
improvement in biostabilization and functionalization because their toxicity. In addition, the 
negative contrast effect and magnetic susceptibility artifacts of iron oxide NPs are significant 
drawbacks. The resulting dark signal can mislead the clinical diagnosis in T2-weighted MRI 
because the signal is often confused with the signals from bleeding, calcification, or metal 
deposits, and the susceptibility artifacts distort the background image. For the extensive 
applications of MRI to diagnostic radiology and therapeutic medicine and to overcome the 
above-mentioned drawbacks of Gd3+- and Mn2+-based T1 contrast agents and MNP-based T2 
contrast agents, there has been great demand for a new class of contrast agent that satisfies 
the following characteristics: 1) positive (T1) contrast ability, 2) intracellular uptake and 
accumulation for imaging cellular distribution and functions, 3) nanoparticulate form for 
easy surface modification and efficient labeling with targeting agents for applications in 
molecular and cellular imaging, and 4) favorable pharmacokinetics and dynamics for easy 
delivery, efficient distribution to biomarkers, and safe clearance from patients with minimal 
side effects. Recently, the development of a long-awaited T1 MRI contrast agent that satisfies 
all of these desirable characteristics was proposed by using MnO NPs (Na et al., 2007). 
6.2 Drug delivery and gene delivery (magnetofection)  
The surface of magnetite NPs have been functionalized with drugs, proteins, and genetic 
materials to achieve localized delivery of therapeutic agents. The need for localized delivery 
of bioactive agents stems in the systemic toxicity often associated with non-targeted 
administration of these agents. Potential elimination of systemic side-effects could 
potentially be achieved through efficient targeting of NPs carrying high payload of active 
agents. Although still the object of much debate the ability to magnetically target in vivo 
drug-loaded MNPs has attracted considerable attention (Dobson, 2006a). Whether an 
external magnetic field can be used to capture MNPs injected intravenously depends on the 
strength of the applied magnetic field, as well as on the magnetic properties and volume of 
the NPs. Alternatively, targeting moieties on the surface of the NPs functionalized with 
bioactive agents have been used to target or internalize specific tissue or tumor in vivo. 
Ideally, they could bear on their surface or in their bulk a pharmaceutical drug that could be 
driven to the target organ and released there. Physical constraints placed upon magnetic 
targeting, such as the rapid diminishing of field strength with target depth in the body and 
the difficulties of bypassing intervening vasculature and tissue structures (Dobson, 2006a; 
Dobson, 2006b), have hampered the clinical realization of this technology. Much of the 
recent work in this area has focused on the development of high-moment MNP carriers with 
novel, multifunctional coatings and novel techniques for enhancing the body own targeting 
systems (Pankhurst et al., 2009). The development of novel MNP carrier formulations 
continues apace. In general, advances are focusing on novel, multifunctional coatings, and 
the use of high-moment materials for the particle cores and the development of 
thermoresponsive hydrogels and particles (Ankareddi & Brazel, 2007). Although there have 
been numerous small animal studies reported since our last review, due to the technical 
barriers mentioned above, the goal of clinical applications remains largely unfulfilled.  
Magnetofection (MF) is a method in which MNPs associated with vector DNA are 
transfected into cells by the influence of an external magnetic field. A high-field, high-
gradient magnet is generally placed underneath a cell culture dish or multi-well plate. The 
particle–gene complex is introduced into the cell growth medium and the magnetic field 
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rapidly pulls the particles into contact with the cells growing on the bottom of the dish. This 
has been shown to promote endocytosis of the particles, resulting in rapid and efficient 
transfection (Pankhurst et al., 2003). By using whether viral or nonviral vectors, MF has been 
shown to enhance the efficiency of the vectors up to several thousand times.  
6.3 Hyperthermia 
The idea of hyperthermia has been recognized as a useful therapeutic modality for treating 
malignant tumors, the idea being that it may be possible to kill cancer, not with drugs, but 
with targeted nanoscale heaters that would essentially cook malignant cells to death from 
the inside out. Magnetic materials with Curie temperatures between 42 and 60 °C are the 
best candidates for effective treatment, since they act as in vivo temperature control switches, 
preventing overheating. It is known that tumor cells are more sensitive to temperature 
increases than healthy cells, therefore intracellular hyperthermia methods have been 
suggested and developed using MNPs, whereby the particles are concentrated at the tumor 
site and remotely heated using an applied magnetic field to required hyperthermic 
temperatures (42–45°C) by hysteresis loss (multidomain particles) or energy dissipation 
(superparamagnetic NPs) (Berry, 2009). Magnetic field is not absorbed by the living tissues 
and can be applied to deep region in the living body. The amount of heat generated depends 
on the nature of magnetic material and of magnetic field parameters. Magnetic particles 
embedded around a tumor site and placed within an oscillating magnetic field will heat up 
to a temperature dependent on the magnetic properties of the material, the strength of the 
magnetic field, and the frequency of oscillation and the cooling capacity of the blood flow in 
the tumor site. Cancer cells are destroyed at temperature higher than 43 °C, whereas the 
normal cells can survive at higher temperatures (Gupta & Gupta, 2005). In a general way, 
when MNPs are injected into an organ with a tumor, they tend to accumulate in the tumor 
due to the unorganized vasculature, thus effectively heating the tumor as opposed to the 
surrounding healthy tissue. Direct injection into solid tumors, followed by exposure to an 
alternating magnetic field, has been shown to be capable of inducing tumor regression. 
Studies have highlighted the potential of MNPs in human cancer models, such as breast 
cancer, whereby 10–30 nm iron oxide particles were heated effectively. Choosing high-
power magnetic particles combined with appropriate external magnetic field, very small 
amounts of magnetic fine particles in the order of tenth of milligram may easily be used to 
raise the temperature of biological tissue locally up to cell necrosis. However, the major 
technical difficulty associated with heat-based cancer therapy is to heat only the tumor 
tissues without damaging the healthy ones. Considerable interest has therefore been drawn 
to MNP to achieve intracellular hyperthermia procedures, for instance by targeting MNPs 
conjugated with a monoclonal antibody such as anti-HER2. In addition, if it is the aim to 
generate enough of a temperature rise throughout the target tissue volume for the induced 
hyperthermia to be therapeutic in its own right, then the method used to get the NPs into 
the target becomes critical (Wust et al., 2006). MagForce have pursued the concept of 
interstitial heating via multiple-site direct injection of their NPs and have developed 
sophisticated measures to ensure that the specific absorption rate (SAR) throughout the 
entire target volume will be enough to result in a therapeutic thermal dose, expressed as 
cumulative equivalent minutes at 43 ◦C for 90% of the tumor volume (Pankhurst et al., 
2009). This is an extremely demanding requirement since it only requires a very small part 
of the target volume to remain cool for the entire treatment to be compromised. The two 
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most obvious reasons why a small section of a tumor may not be heated are either because 
of a locally increased level of blood flow, say because of a nearby blood vessel, or an 
inadequate concentration of implanted MNPs. 
A study highlights the difficulty in obtaining a uniformly effective thermal dose throughout 
the tumor volume. Animal model was used to examine the effect on tumor growth of NP-
mediated hyperthermia by comparing two methods of NP administration. In one group, 
small deposits of a viscous emulsion of MNPs were injected directly into the centre of the 
tumors (group 1), while in the second group microspheres (ca 30μm in diameter) containing 
the same type of MNPs were administered via the arterial blood supply to the tumors 
(group 2). In both cases the thermal response, as measured by discrete temperature probes 
located in and around the tumor, appeared to be adequate although the group 1 heated 
much more rapidly than the group 2. The somewhat unexpected result, however, was that 
the therapeutic outcomes were very different and revealed a distinct advantage of the 
second approach, despite an apparently inferior thermal response initially. This result could 
be explained by the differences in the distribution of the magnetic particles throughout the 
tumor that are not reflected in the measured thermal response (Moroz et al., 2002). 
6.4 Tissue repair – tissue engineering (TE) and regenerative medicine (RM) 
Tissue repair using MNPs is accomplished either through welding, apposing two tissue 
surfaces then heating the tissues sufficiently to join them, or through soldering, where 
protein or synthetic polymer-coated NPs are placed between two tissue surfaces to enhance 
joining of the tissues. Temperatures greater than 50°C are known to induce tissue union. 
This is believed to be induced by the denaturation of proteins and the subsequent 
entanglement of adjacent protein chains (Gupta & Gupta, 2005). NPs that strongly absorb 
light corresponding to the output of a laser are also useful for tissue-repairing procedures. 
Specifically, gold- or silica-coated MNPs have been designed to strongly absorb light. The 
NPs are coated onto the surfaces of two pieces of tissue at the site where joining was 
desired. This technique affords methods to minimize tissue damage by using the least 
harmful wavelengths of light and/or lower powered light sources. Stem cells are the body 
master cells and have a unique ability to renew them and give rise to other specialized cell 
types. These cells, therefore, have the potential to be used for transplantation purposes, for 
example, to replace degenerated cells or repairing of a damaged tissue, providing signals so 
that the stem cells can yield the appropriate cell types for the development of a tissue. An 
obstacle to developing such therapy is a lack of targeting strategies on both neural stem cells 
and on the signals that determine their behavior and fate for tissue development. The 
superparamagnetic NPs could be coupled to the cells and used to target these cells at the 
desired site in the body. In addition, various proteins, growth factors, etc., could be bound 
to these NPs that might be delivered at the damaged tissue, where it would play a role in 
tissue development (Gupta & Gupta, 2005). In this context, over the past decade another 
novel application of MNPs has emerged: nanomagnetic actuation for TE and RM. Magnetic 
actuation can also be used to influence the growth and differentiation characteristics of stem 
cells. For many TE/RM applications, mechanical cues provide vitally important stimuli to 
the cells that promote the production of functional tissue matrix, especially bone, cartilage, 
muscle and connective tissue. However, applying the correct stress profiles to cells growing 
in a 3D scaffold within a bioreactor or within a patient’s body has proven difficult. To 
overcome this problem, nanomagnetic actuation has been developed to apply targeted, 
controlled stress to cells growing in bioreactors and in vivo (Pankhurst et al., 2009). Although 
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the use of MNPs for TE/RM and stem cell research and therapy is at an early stage, the 
potential for this technology to make a major contribution to this field is great. 
6.5 Cellular labeling and cell separation 
Cell labeling with MNPs is an increasingly common method for in vivo cell separation 
(Olsvik et al., 1994) as the labeled cells can also be detected by MRI. Most current labeling 
techniques utilize either of two approaches: (a) attaching MNPs to the cell surface or (b) 
internalizing biocompatible magnetic particles by fluid phase endocytosis, receptor-
mediated endocytosis or phagocytosis (Gupta & Gupta, 2005). One strategy for efficient and 
specific cell labelling of MNPs is to modify their surface with a ligand efficient to taken up 
by target cells. Targeting agents (e.g. transferrin, lactoferrin, albumin, insulin, growth 
factors, etc.) have been shown preference for target cell surface, because the receptors for 
these ligands are frequently overexpressed on the mammalian cells surface (Qian et al., 
2002). These receptors are not only cellular markers, but also have been shown efficiency in 
the internalize molecules coupled to them. Furthermore, many of these ligands are stable, 
and generally poorly immunogenic. In the absence of any system to inhibit endocytosis, 
most NPs are endocytosed by cells and eventually sequestered in digestive vacuoles in the 
cell. Once the particles are endocytosed, they are probably removed from contact with 
specific cell surface receptors and become effectively ineffective. As a result of these events, 
the cells are at high risk of apoptosis from overload with particles. If the particles can be 
prevented from leaving the cell surface, they will remain in contact with their specific 
receptors and would be expected to leave the cell in a state of prolonged stimulation while 
protecting the cells from side effects due to endocytosis (Gupta & Gupta, 2005).  
7. Challengers and trends 
Although significant advances were obtained, the challengers faced by using MNPs in vivo 
still remains such as: need to extend the particles blood circulation time, the difficult to 
targeting specific tissue, and, more recently, due to increasing the complexity of the 
multifunctions by derivatized-layered coating the MNP surface generally using no-magnetic 
materials, there is a need to improve the magnetic core emanation in order to support these 
multifunctional capping. The need to extend NPs blood circulation time to allow for their 
accumulation in target tissues has long been recognized as one of the primary challenges in 
the development of MNPs (Berry, 2009; Sun et al., 2008). The ability to evade uptake by the 
RES is critical to achieving a long blood half-life. Like other colloidal carriers, the 
physicochemical properties of these MNP platforms, such as size, morphology, charge, and 
surface chemistry, dictate their fate in vivo, since determine their pharmacokinetics, toxicity, 
and biodistribution. The overall size of MNPs must be sufficiently small to evade rapid 
splenic filtration but large enough to avoid renal clearance. NPs larger than 200 nm are 
sequestered by phagocytotic cells of the spleen, while particles smaller than 5.5 nm are 
rapidly removed through renal clearance (Berry, 2009). In addition, particles smaller than 40 
nm present both biodistribution and half-life determined by the coating materials rather 
than the mean hydrated size (Briley-Saebo et al., 2004). Particles that escape filtration are 
then subject to opsonization resulting in recognition and clearance by Kupffer cells and 
other tissue macrophages. Coatings including hydrophilic polymers, such as PEG, have 
been utilized to create a non-fouling coating on the particle surface. In addition to the 
biofouling nature of MNPs, surface charge plays a critical role in blood half-lives of colloids 
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and polymers. Positively charged polymers and particles tend to non-specifically stick to 
cells. This non-specific adsorption can have a significant impact on blood half-life. Strong 
negative charges on the particle surface are also detrimental in that they result in increased 
liver uptake. Therefore, it is generally agreed that NPs with a neutral surface experience 
extended blood circulation times. The development of long-circulating NPs has allowed for 
many MNP platforms to exploit structural abnormalities in the vasculature of particular 
pathologies, such as tumors, inflammatory, and infectious sites. This phenomenon, known 
as the enhance permeability and retention (EPR) effect, is based on the mechanism that these 
tissues possess “leaky” vasculature which allows macromolecules and NPs to extravasate 
and accumulate more readily. In the case of tumors, poorly organized vascular beds also 
result in impaired lymphatic drainage from these tissues. This nonspecific accumulation, or 
passive targeting, has been demonstrated with NPs ranging from 10 to 500 nm in diameter. 
Passive targeting can also occur through the inherent clearance by the RES. Comprised of 
bone marrow progenitors, blood monocytes, and tissue macrophages, the uptake of MNPs 
by these phagocytic cells provides a means of delivering contrast agents and drug carriers to 
related organs. One promising approach toward increasing the local accumulation of MNPs 
in diseased tissue, known as active targeting or specific targeting, is by the conjugation of 
targeting molecules that possess high affinity toward unique molecular signatures found on 
malignant cells. Often augmented by the EPR effect, these receptor–ligand or antigen–
antibody interactions provide an effective strategy to improve the residence time in 
malignant tissues, such as tumors. Targeting ligands, such as proteins, peptides, aptamers, 
and small molecules, have been investigated to increase the site specific accumulation of 
MNPs. In some cases, specific binding can also facilitate internalization of the NP by 
receptor-mediated endocytosis. Another area of extensive investigation has been the 
targeting of MNPs to receptors overexpressed on tumor neovasculature. The formation of 
new blood vessels, or angiogenesis, is an essential component of tumor growth and has been 
shown to be highly specific for neoplasia (Sun et al., 2008). The use of short peptides and 
small molecules as targeting agents also offers the advantage of increased binding affinity 
through multivalent attachment (Weissleder et al., 2005). This targeting phenomenon has 
been examined with folic acid, a vitamin whose receptor is overexpressed on the surface of 
many human tumor cells, including ovarian, lung, breast, endometrial, renal, and colon 
cancers (Ross et al., 1994). Another advantage of utilizing small molecules as targeting 
agents is that they are generally more robust than proteins or peptides thereby reducing 
possibility of loss of functionality through the synthesis of such MNPs. An essential step in 
the use of MNPs for drug delivery is the internalization of the MNP and/or its therapeutic 
payload, as well as the subsequent release of these therapeutic agents to cell cytoplasm for 
desired actions to take place. Several mechanisms have been proposed to describe the 
uptake of NPs into cells, including receptor-mediated endocytosis  and internalization by 
caveolae structures (Berry & Curtis, 2003). NP size and surface properties play a critical role 
in moving across the plasma membrane. NPs smaller than 50 nm or those coated with 
lipophilic polymers, such as PEG, have been shown to efficiently diffuse through cell 
membranes (Zhang et al., 2002). Although general guidelines, such as those discussed in 
regard to the physicochemical properties of MNPs, may provide some insight on their 
behavior in the body, no universal set of criteria has been elucidated to predict this critical 
aspect of nanomedicine. Mechanisms of clearance can vary significantly depending on the 
wide range of structures that are employed in the development of MNPs. One can make the 
obvious distinction that the metabolism, clearance, and toxicity profiles associated with a 
www.intechopen.com
Magnetic and Multifunctional Magnetic Nanoparticles in Nanomedicine: Challenges  
and Trends in Synthesis and Surface Engineering for Diagnostic and Therapy Applications 
 
419 
gold-coated FePt core–shell NP will be drastically different from that of an iron oxide filled 
liposome and these structures therefore necessitate their individual evaluation. Recently, 
increased emphasis has been placed on standardizing preclinical characterization of 
biomedical NPs to better elucidate structure-activity relationships (SARs) (Sun et al., 2008).  
Recently, a new challenger involving MNPs or MFMNPs seems to be related with the core 
emanation. Several coating and molecular/compounds used to change de MNP surface 
from naked to multifunctional biocompatible and targeting leads also to dramatically 
decrease in the magnetic core emanation. In this context, either, new magnetic materials or 
combined magnetic materials in an enhanced new composite must be used in order to 
preserve the magnetic signal response of the external field (Varanda et al., 2008).  
8. Conclusion 
Progress and uses of MNPs in biomedicine have been highlighted, in both the traditional 
targeting and imaging, as well as the more novel cell manipulation techniques, it is believed 
that the future of MNP development must be directed towards further improving on the 
biocompatibility, specific targeting and image resolution available, extent the blood 
circulation time, and improvement of the magnetic core emanation in order to support the 
additional coating for multifunctionality. In addition, the potential of MNPs to have a 
multifunctional role in diagnosis, monitoring and treatment, is an exciting prospect. 
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